C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 417/12 (2006.01) A61K 31/425 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2656915
The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-.beta.) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising one or more human protein tyrosine phosphatase beta (HPTP-.beta.) inhibitors, and to methods for regulating angiogenesis.
La présente invention concerne des composés efficaces comme inhibiteurs de la protéine humaine tyrosine phosphatase bêta (HPTP-.beta.) régulant l'angiogenèse. Cette invention concerrne également des compositions comprenant des inhibiteurs de la protéine humaine phosphatase bêta (HPTP-.beta.), ainsi que des procédés de régulation de l'angiogenèse.
Amarasinghe Kande
Clark Cynthia Monesa
Gray Jeffrey Lyle
Maier Matthew Brian
Nichols Ryan
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
The Procter & Gamble Company
Warner Chilcott Company Llc
LandOfFree
Human protein tyrosine phosphatase inhibitors and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human protein tyrosine phosphatase inhibitors and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human protein tyrosine phosphatase inhibitors and methods of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2060469